CXCR4 and breast carcinoma: In addition, nobiletin showed the effect of inhibiting metastasis by downregulating CXC chemokine receptor type 4 (CXCR4) and matrix metallopeptidase-9 on MDA-MB 231 breast cancer cells (Baek et al., 2012).